REVB
Revelation Biosciences
$1.06
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame REVB today
- Market cap
- $4.14M
- P/E (TTM)
- -0.4
- EV / FCF
- 1.1
- ROIC
- 1,253.2%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.88
- 52wk High
- $11.96
Growth
Revenue and earnings trend for REVB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about REVB
Is Revelation Biosciences a good buy?
No. Revelation Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of REVB?
Revelation Biosciences's market capitalization is $4.14M.
What is the P/E ratio for REVB stock?
Revelation Biosciences's current P/E ratio is -0.4.
What is the 52-week high for REVB stock?
The 52-week high for Revelation Biosciences is $11.96. The current close of $1.06 is 91.1% below that high.
What is the 52-week low for REVB stock?
The 52-week low for Revelation Biosciences is $0.88. The current close of $1.06 is 21.1% above that low.
Does REVB stock pay dividends?
Revelation Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for REVB?
Revelation Biosciences's Debt / Equity ratio is 0.06.